MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$14,438,792
Prepaid expenses and
other current assets
$664,685
Total current assets
$15,103,477
Non-current prepaid
clinical trial costs
$819,721
Total assets
$15,923,198
Total liabilities and
stockholders equity
$15,923,198
Total stockholders'
equity
$8,647,645
Total liabilities
$7,275,553
Accumulated deficit
-$184,137,952
Additional paid-in capital
$192,773,942
Total current
liabilities
$7,275,553
Common stock, par value
of 0.0001...
$11,655
Accounts payable
$3,009,074
Accrued clinical
expenses
$2,582,094
Other accrued
liabilities
$791,611
Accrued compensation
$485,899
Short-term debt
$406,875
Back
Back
Balance Sheet
source: myfinsight.com
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)